Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel acetyl-CoA carboxylase inhibitors developed in India

July 31, 2012

Cadila Healthcare divulges novel LDL receptor ligands

July 31, 2012

Takeda resubmits alogliptin product NDAs

July 30, 2012

Arena Pharmaceuticals transfers NDA rights to Eisai

July 30, 2012

Chinese researchers discover novel DPP IV inhibitors

July 30, 2012

FDA approves Vascepa to reduce triglyceride levels in adults with severe hypertriglyceridemia

July 27, 2012

U.S. researchers report novel glucagon receptor agonists

July 27, 2012

Biodel awarded NIH grant to develop concentrated ultrarapid-acting insulin

July 27, 2012

New protein kinase inhibitors synthesized at Sanofi

July 26, 2012

European Commission approves combination tablet for type 2 diabetes

July 25, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...